Lifestyle
Moderna, Merck mRNA Cancer Vaccine Shows Positive Phase 3 Results in Melanoma Trial
Moderna and Merck's personalised mRNA cancer vaccine with Keytruda shows positive Phase 3 results, reducing melanoma recurrence and spread…
2 stories
Moderna and Merck's personalised mRNA cancer vaccine with Keytruda shows positive Phase 3 results, reducing melanoma recurrence and spread…
Health experts urge the government to update India's NLEM, saying missing cancer drugs like Keytruda are limiting access to affordable…
The stories that matter, in your inbox by 8 AM. Free, no spam.